Ajay Samkaria: Prevention of Alloimmunization in Females of Childbearing Age
Ajay Samkaria, Product and Application Manager at Diagast Transfusion Medicine, shared a post on LinkedIn:
“In transfusion medicine, prevention is always better than reaction.
One of the most critical yet often under-emphasized practices is extended phenotyping – especially for Rh (C, c, E, e) and Kell antigens in females.
Why does this matter?
Because alloimmunization doesn’t just affect a single transfusion – it can impact future pregnancies and neonatal outcomes.
A young female patient exposed to mismatched Rh or Kell antigens today may develop clinically significant antibodies tomorrow.
These antibodies can lead to Hemolytic Disease of the Fetus and Newborn (HDFN), posing serious risks to both mother and baby.
By proactively providing Rh and Kell matched blood for females of childbearing age, we are not just ensuring safe transfusion – we are protecting future lives.
This is not just good practice.
It is responsible transfusion medicine.
Let’s move from compatibility to foresight.”
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care